No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Accelerated approval
3
Oct 16, 2019 01:54PM
7
Oct 16, 2019 02:30PM
4
Oct 16, 2019 05:51PM
3
Oct 16, 2019 06:34PM
4
Oct 17, 2019 12:43PM
3
Oct 17, 2019 12:48PM
3
Oct 18, 2019 05:58PM

Thanks for straightening me out RVXoldtimer. I had forgetten about the Pfizer contribution and it was the TNBC trial I was referring to.

It's a good sign but many miles to go in what I am beginning to believe is a very competitive field. 

Also, thanks bear for the TNBC trial update. Things are progressing.

GLTA

Toinv

Share
New Message
Please login to post a reply